Waxman Bill Would Alter OTC Ad Rules, Streamline FDA Monograph Authority
This article was originally published in The Tan Sheet
Executive Summary
Democrats are seeking to significantly increase FDA authority over over-the-counter drug monographs and potentially change the face of OTC advertising, prompted by recent high-profile concerns over pediatric cough/cold medications
You may also be interested in...
Acetaminophen Risk Management On Tap For Joint Advisory Panel
FDA is looking for risk-management solutions to liver problems linked to the misuse of acetaminophen in OTC and prescription products, and will convene a joint advisory panel to discuss potential steps to take
Acetaminophen Risk Management On Tap For Joint Advisory Panel
FDA is looking for risk-management solutions to liver problems linked to the misuse of acetaminophen in OTC and prescription products, and will convene a joint advisory panel to discuss potential steps to take
Acetaminophen Risk Management On Tap For Joint Advisory Panel
FDA is looking for risk-management solutions to liver problems linked to the misuse of acetaminophen in OTC and prescription products, and will convene a joint advisory panel to discuss potential steps to take